Beyond Genes: Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine.

Beyond Genes: Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine.

Publication date: Sep 05, 2019

The increasing availability of high throughput proteomics data provides us with opportunities as well as posing new ethical challenges regarding data privacy and re-identifiability of participants. Moreover, the fact that proteomics represents a level between the genotype and the phenotype further exacerbates the situation, introducing dilemmas related to publicly available data, anonymization, ownership of information and incidental findings. In this paper, we try to differentiate proteomics from genomics data and cover the ethical challenges related to proteomics data sharing. Finally, we give an overview of the proposed solutions and the outlook for future studies.

Boonen, K., Hens, K., Menschaert, G., Baggerman, G., Valkenborg, D., and Ertaylan, G. Beyond Genes: Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine. 05365. 2019 Genes (Basel) (10):9.

Concepts Keywords
Basel Genomics
Genotype Proteomics
Phenotype Anonymity
Privacy Data anonymization
Proteomics Branches of biology
Throughput Proteomics
Genotype

Semantics

Type Source Name
disease MESH incidental findings
disease MESH privacy

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *